Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (211-220 of 610) with videos related to

Pageof 61
Sort By:
Blood Transfusion = Trasfusione Del Sangue|January 13, 2018
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"Andrea Messori, Flora Peyvandi, Sabrina Trippoli, et al.
The Journal of Biological Chemistry|January 15, 2004
A natural prothrombin mutant reveals an unexpected influence of A-chain structure on the activity of human alpha-thrombinRaimondo De Cristofaro, Sepideh Akhavan, Cosimo Altomare, et al.
International Journal of Hematology|November 21, 2015
Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxabanArmando Tripodi, Ida Martinelli, Veena Chantarangkul, et al.
Biomedicines|February 25, 2022
Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and ConsequencesArmando Tripodi, Rosa Lombardi, Massimo Primignani, et al.
American Journal of Hematology|July 2, 2013
ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentratesFlora Peyvandi, Pier M Mannucci, Carla Valsecchi, et al.
European Journal of Internal Medicine|November 27, 2016
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpuraIlaria Mancini, Barbara Ferrari, Carla Valsecchi, et al.
Research and Practice in Thrombosis and Haemostasis|December 1, 2025
Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometryArmando Tripodi, Marigrazia Clerici, Erica Scalambrino, et al.
International Journal of Laboratory Hematology|June 8, 2023
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitorsPiet Meijer, Flora Peyvandi, Guy Young, et al.
Annals of Hematology|January 19, 2026
Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literatureSilvio Rao, Arianna Liparoti, Juri Alessandro Giannotta, et al.
Internal and Emergency Medicine|August 3, 2021
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: commentRaffaella Rossio, Mauro Tettamanti, Alessandro Nobili, et al.
Pageof 61

Showing results (211-220 of 610) with videos related to

Sort By:
Pageof 61
Blood Transfusion = Trasfusione Del Sangue|January 13, 2018
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"Andrea Messori, Flora Peyvandi, Sabrina Trippoli, et al.
The Journal of Biological Chemistry|January 15, 2004
A natural prothrombin mutant reveals an unexpected influence of A-chain structure on the activity of human alpha-thrombinRaimondo De Cristofaro, Sepideh Akhavan, Cosimo Altomare, et al.
International Journal of Hematology|November 21, 2015
Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxabanArmando Tripodi, Ida Martinelli, Veena Chantarangkul, et al.
Biomedicines|February 25, 2022
Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and ConsequencesArmando Tripodi, Rosa Lombardi, Massimo Primignani, et al.
American Journal of Hematology|July 2, 2013
ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentratesFlora Peyvandi, Pier M Mannucci, Carla Valsecchi, et al.
European Journal of Internal Medicine|November 27, 2016
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpuraIlaria Mancini, Barbara Ferrari, Carla Valsecchi, et al.
Research and Practice in Thrombosis and Haemostasis|December 1, 2025
Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometryArmando Tripodi, Marigrazia Clerici, Erica Scalambrino, et al.
International Journal of Laboratory Hematology|June 8, 2023
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitorsPiet Meijer, Flora Peyvandi, Guy Young, et al.
Annals of Hematology|January 19, 2026
Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literatureSilvio Rao, Arianna Liparoti, Juri Alessandro Giannotta, et al.
Internal and Emergency Medicine|August 3, 2021
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: commentRaffaella Rossio, Mauro Tettamanti, Alessandro Nobili, et al.
Pageof 61